Protein biomarker signatures of preeclampsia - a longitudinal 5000-multiplex proteomics study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Protein biomarker signatures of preeclampsia - a longitudinal 5000-multiplex proteomics study ; volume:14 ; number:1 ; day:10 ; month:10 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (10.10.2024), 1-14, 12.2024
- Urheber
-
Degnes, Maren-Helene Langeland
Westerberg, Ane Cecilie
Andresen, Ina Jungersen
Henriksen, Tore
Roland, Marie Cecilie Paasche
Zucknick, Manuela
Michelsen, Trond Melbye
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-73796-9
- URN
-
urn:nbn:de:101:1-2412272104387.082276720757
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Degnes, Maren-Helene Langeland
- Westerberg, Ane Cecilie
- Andresen, Ina Jungersen
- Henriksen, Tore
- Roland, Marie Cecilie Paasche
- Zucknick, Manuela
- Michelsen, Trond Melbye
- SpringerLink (Online service)
Ähnliche Objekte (12)
Revisiting biomarker discovery by plasma proteomics
Proteomics reveals unique plasma signatures in constitutional thinness
Myeloperoxidase is not a good biomarker for preeclampsia prediction
Applications of urinary proteomics in biomarker discovery
Multiplex serum biomarker assessments: technical and biostatistical issues
Quantitative shotgun proteomics distinguishes wound-healing biomarker signatures in common carp skin mucus in response to Ichthyophthirius multifiliis
Lipidomic signatures in patients with early-onset and late-onset Preeclampsia
Maximizing biomarker discovery by minimizing gene signatures
Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia
Author Correction: Myeloperoxidase is not a good biomarker for preeclampsia prediction
Revisiting biomarker discovery by plasma proteomics
Proteomics reveals unique plasma signatures in constitutional thinness
Myeloperoxidase is not a good biomarker for preeclampsia prediction
Applications of urinary proteomics in biomarker discovery
Multiplex serum biomarker assessments: technical and biostatistical issues
Quantitative shotgun proteomics distinguishes wound-healing biomarker signatures in common carp skin mucus in response to Ichthyophthirius multifiliis
Lipidomic signatures in patients with early-onset and late-onset Preeclampsia
Maximizing biomarker discovery by minimizing gene signatures
Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia
Author Correction: Myeloperoxidase is not a good biomarker for preeclampsia prediction
Revisiting biomarker discovery by plasma proteomics
Proteomics reveals unique plasma signatures in constitutional thinness
Myeloperoxidase is not a good biomarker for preeclampsia prediction
Applications of urinary proteomics in biomarker discovery
Multiplex serum biomarker assessments: technical and biostatistical issues
Quantitative shotgun proteomics distinguishes wound-healing biomarker signatures in common carp skin mucus in response to Ichthyophthirius multifiliis
Lipidomic signatures in patients with early-onset and late-onset Preeclampsia
Maximizing biomarker discovery by minimizing gene signatures
Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
The Role of Ischemia-modified Albumin as a Biomarker in Preeclampsia